Intercept Pharmaceuticals Downgraded By: Benzinga via Benzinga May 20, 2015 at 08:27 AM EDT Bank of America downgraded Intercept Pharmaceuticals Inc (NASDAQ: ICPT) Tuesday from Buy to Neutral and maintained a $315 price ... Read More >> Related Stocks: Intercept Pharmaceuticals